High Flow Needle Sets Market Size

High Flow Needle Sets Market Analysis

The global high flow needle sets market is expected to grow at a CAGR of 6.6% over the forecast period. Rising prevalence of diabetes owing to growing number of baby boomers is a key factor for market growth. High flow needles are used when there is a need of administering more viscous drugs into the body. According to the International Diabetes Federation, approximately 463 million adults were living with diabetes in 2019 and this number is expected to reach 700 million in 2045 which will further bolster the overall growth.

In addition, new product launches by major companies across the globe to introduce technology with maximum safety and precision is expected to contribute to the market expansion. For instance, RMS medical products received FDA 510(k) clearance for high-flo super26 subcutaneous needle sets which allows subcutaneous infusion of medications in the home, hospital, or ambulatory settings to facilitate high flow rates. Factors such as the safe delivery and efficacy of subcutaneous therapies, promote compliance, and prompt use design were favorable with the majority of health care personnel preferring high flow needle technology as compared to conventional needles.

Certain treatment regimens are associated with pain and anxiety where various psychological and physical factors trigger the pain receptors of the brain. For instance, there is a close association of pain and anxiety with dental injection during dental procedures. These factors boost the high flow needles set market over forecast period. However, low adaptation of the high flow needle sets in under developing regions may restrict the market.